Can We Slow Down Biological Age Progression? Study Protocol for the proBNPage Reduction (PBAR) Randomized, Double-Blind, Placebo-Controlled Trial (Effects of 4 “Anti-Aging” Food Supplements in Healthy Older Adults)

PURPOSE: The availability of a simple and reliable marker of biological age might allow an acceleration of the research in the field of longevity extension. Previous studies suggest that this marker might be the N-terminal of B-type natriuretic peptide precursor (NT-proBNP), from which proBNPage, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Muscari, Antonio, Forti, Paola, Brizi, Mara, Magalotti, Donatella, Capelli, Eleonora, Potì, Simona, Piro, Filomena, Pandolfi, Paolo, Perlangeli, Vincenza, Ramazzotti, Eric, Barbara, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617523/
https://www.ncbi.nlm.nih.gov/pubmed/37915546
http://dx.doi.org/10.2147/CIA.S422371
_version_ 1785129609435545600
author Muscari, Antonio
Forti, Paola
Brizi, Mara
Magalotti, Donatella
Capelli, Eleonora
Potì, Simona
Piro, Filomena
Pandolfi, Paolo
Perlangeli, Vincenza
Ramazzotti, Eric
Barbara, Giovanni
author_facet Muscari, Antonio
Forti, Paola
Brizi, Mara
Magalotti, Donatella
Capelli, Eleonora
Potì, Simona
Piro, Filomena
Pandolfi, Paolo
Perlangeli, Vincenza
Ramazzotti, Eric
Barbara, Giovanni
author_sort Muscari, Antonio
collection PubMed
description PURPOSE: The availability of a simple and reliable marker of biological age might allow an acceleration of the research in the field of longevity extension. Previous studies suggest that this marker might be the N-terminal of B-type natriuretic peptide precursor (NT-proBNP), from which proBNPage, a biological age surrogate, can be calculated. Objectives of the study: 1) To fine-tune the method of proBNPage progression assessment and 2) To establish whether 4 “anti-aging” treatments, which provided promising results in previous studies, can modify proBNPage progression. PATIENTS AND METHODS: This is a double-blind randomized placebo-controlled clinical trial on 120 adults aged 65–80 years, free of cardiovascular diseases. Participants will be randomized into 3 groups: A) Coenzyme Q10 100 mg bid + Selenium 100 mcg; B) Resveratrol 350 mg bid + TA-65 (Astragalus Membranaceus extract) 100U; C) Placebo-1 bid + Placebo-2. They will be followed for 2 years and checked 8 times, to assess both proBNPage progression and treatment safety. Secondary variables (handgrip strength, aerobic capacity at the step test and quality of life) will also be assessed. Primary outcome will be the demonstration of significant changes of proBNPage, compared to baseline, in the 3 groups at 6, 12, 18 and 24 months. Secondary outcome will be the demonstration of similar changes of secondary variables. Statistical analyses will be mainly performed by repeated measures ANOVA (both according to intention to treat and per protocol) and paired t tests. The study was approved by the Ethics Committee Area Vasta Emilia Centro, Emilia-Romagna Region, ID: 64/2022/Sper/AOUBo. Trial registration: ClinicalTrials.gov, NCT05500742. CONCLUSION: The use of proBNPage as a surrogate of biological age may prove an easy method to select anti-aging treatments worthy of further, more complex assessments.
format Online
Article
Text
id pubmed-10617523
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-106175232023-11-01 Can We Slow Down Biological Age Progression? Study Protocol for the proBNPage Reduction (PBAR) Randomized, Double-Blind, Placebo-Controlled Trial (Effects of 4 “Anti-Aging” Food Supplements in Healthy Older Adults) Muscari, Antonio Forti, Paola Brizi, Mara Magalotti, Donatella Capelli, Eleonora Potì, Simona Piro, Filomena Pandolfi, Paolo Perlangeli, Vincenza Ramazzotti, Eric Barbara, Giovanni Clin Interv Aging Study Protocol PURPOSE: The availability of a simple and reliable marker of biological age might allow an acceleration of the research in the field of longevity extension. Previous studies suggest that this marker might be the N-terminal of B-type natriuretic peptide precursor (NT-proBNP), from which proBNPage, a biological age surrogate, can be calculated. Objectives of the study: 1) To fine-tune the method of proBNPage progression assessment and 2) To establish whether 4 “anti-aging” treatments, which provided promising results in previous studies, can modify proBNPage progression. PATIENTS AND METHODS: This is a double-blind randomized placebo-controlled clinical trial on 120 adults aged 65–80 years, free of cardiovascular diseases. Participants will be randomized into 3 groups: A) Coenzyme Q10 100 mg bid + Selenium 100 mcg; B) Resveratrol 350 mg bid + TA-65 (Astragalus Membranaceus extract) 100U; C) Placebo-1 bid + Placebo-2. They will be followed for 2 years and checked 8 times, to assess both proBNPage progression and treatment safety. Secondary variables (handgrip strength, aerobic capacity at the step test and quality of life) will also be assessed. Primary outcome will be the demonstration of significant changes of proBNPage, compared to baseline, in the 3 groups at 6, 12, 18 and 24 months. Secondary outcome will be the demonstration of similar changes of secondary variables. Statistical analyses will be mainly performed by repeated measures ANOVA (both according to intention to treat and per protocol) and paired t tests. The study was approved by the Ethics Committee Area Vasta Emilia Centro, Emilia-Romagna Region, ID: 64/2022/Sper/AOUBo. Trial registration: ClinicalTrials.gov, NCT05500742. CONCLUSION: The use of proBNPage as a surrogate of biological age may prove an easy method to select anti-aging treatments worthy of further, more complex assessments. Dove 2023-10-27 /pmc/articles/PMC10617523/ /pubmed/37915546 http://dx.doi.org/10.2147/CIA.S422371 Text en © 2023 Muscari et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Study Protocol
Muscari, Antonio
Forti, Paola
Brizi, Mara
Magalotti, Donatella
Capelli, Eleonora
Potì, Simona
Piro, Filomena
Pandolfi, Paolo
Perlangeli, Vincenza
Ramazzotti, Eric
Barbara, Giovanni
Can We Slow Down Biological Age Progression? Study Protocol for the proBNPage Reduction (PBAR) Randomized, Double-Blind, Placebo-Controlled Trial (Effects of 4 “Anti-Aging” Food Supplements in Healthy Older Adults)
title Can We Slow Down Biological Age Progression? Study Protocol for the proBNPage Reduction (PBAR) Randomized, Double-Blind, Placebo-Controlled Trial (Effects of 4 “Anti-Aging” Food Supplements in Healthy Older Adults)
title_full Can We Slow Down Biological Age Progression? Study Protocol for the proBNPage Reduction (PBAR) Randomized, Double-Blind, Placebo-Controlled Trial (Effects of 4 “Anti-Aging” Food Supplements in Healthy Older Adults)
title_fullStr Can We Slow Down Biological Age Progression? Study Protocol for the proBNPage Reduction (PBAR) Randomized, Double-Blind, Placebo-Controlled Trial (Effects of 4 “Anti-Aging” Food Supplements in Healthy Older Adults)
title_full_unstemmed Can We Slow Down Biological Age Progression? Study Protocol for the proBNPage Reduction (PBAR) Randomized, Double-Blind, Placebo-Controlled Trial (Effects of 4 “Anti-Aging” Food Supplements in Healthy Older Adults)
title_short Can We Slow Down Biological Age Progression? Study Protocol for the proBNPage Reduction (PBAR) Randomized, Double-Blind, Placebo-Controlled Trial (Effects of 4 “Anti-Aging” Food Supplements in Healthy Older Adults)
title_sort can we slow down biological age progression? study protocol for the probnpage reduction (pbar) randomized, double-blind, placebo-controlled trial (effects of 4 “anti-aging” food supplements in healthy older adults)
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617523/
https://www.ncbi.nlm.nih.gov/pubmed/37915546
http://dx.doi.org/10.2147/CIA.S422371
work_keys_str_mv AT muscariantonio canweslowdownbiologicalageprogressionstudyprotocolfortheprobnpagereductionpbarrandomizeddoubleblindplacebocontrolledtrialeffectsof4antiagingfoodsupplementsinhealthyolderadults
AT fortipaola canweslowdownbiologicalageprogressionstudyprotocolfortheprobnpagereductionpbarrandomizeddoubleblindplacebocontrolledtrialeffectsof4antiagingfoodsupplementsinhealthyolderadults
AT brizimara canweslowdownbiologicalageprogressionstudyprotocolfortheprobnpagereductionpbarrandomizeddoubleblindplacebocontrolledtrialeffectsof4antiagingfoodsupplementsinhealthyolderadults
AT magalottidonatella canweslowdownbiologicalageprogressionstudyprotocolfortheprobnpagereductionpbarrandomizeddoubleblindplacebocontrolledtrialeffectsof4antiagingfoodsupplementsinhealthyolderadults
AT capellieleonora canweslowdownbiologicalageprogressionstudyprotocolfortheprobnpagereductionpbarrandomizeddoubleblindplacebocontrolledtrialeffectsof4antiagingfoodsupplementsinhealthyolderadults
AT potisimona canweslowdownbiologicalageprogressionstudyprotocolfortheprobnpagereductionpbarrandomizeddoubleblindplacebocontrolledtrialeffectsof4antiagingfoodsupplementsinhealthyolderadults
AT pirofilomena canweslowdownbiologicalageprogressionstudyprotocolfortheprobnpagereductionpbarrandomizeddoubleblindplacebocontrolledtrialeffectsof4antiagingfoodsupplementsinhealthyolderadults
AT pandolfipaolo canweslowdownbiologicalageprogressionstudyprotocolfortheprobnpagereductionpbarrandomizeddoubleblindplacebocontrolledtrialeffectsof4antiagingfoodsupplementsinhealthyolderadults
AT perlangelivincenza canweslowdownbiologicalageprogressionstudyprotocolfortheprobnpagereductionpbarrandomizeddoubleblindplacebocontrolledtrialeffectsof4antiagingfoodsupplementsinhealthyolderadults
AT ramazzottieric canweslowdownbiologicalageprogressionstudyprotocolfortheprobnpagereductionpbarrandomizeddoubleblindplacebocontrolledtrialeffectsof4antiagingfoodsupplementsinhealthyolderadults
AT barbaragiovanni canweslowdownbiologicalageprogressionstudyprotocolfortheprobnpagereductionpbarrandomizeddoubleblindplacebocontrolledtrialeffectsof4antiagingfoodsupplementsinhealthyolderadults
AT canweslowdownbiologicalageprogressionstudyprotocolfortheprobnpagereductionpbarrandomizeddoubleblindplacebocontrolledtrialeffectsof4antiagingfoodsupplementsinhealthyolderadults